Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Mechanism Study of Senicapoc in Mild or Prodromal Alzheimer's Disease

NCT04804241 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT04804241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Mechanism Study of Senicapoc in Mild or Prodromal Alzheimer's Disease
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Recruiting
Start date
March 18, 2022
Completion date
December 31, 2027
Enrollment
55 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment